Copper oxodotreotide Cu-64
Also known as: 64Cu‑DOTATOC, Copper‑64 DOTATOC, Cu‑64 oxodotreotide
Source Copper oxodotreotide Cu-64 at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Cu‑64‑labeled oxodotreotide is a radiopharmaceutical used experimentally for PET imaging of SSTR2‑expressing neuroendocrine tumors. The peptide chelates Cu‑64 via a DOTA moiety, providing high‑resolution PET signal.
Mechanism of Action
high‑affinity agonist of somatostatin receptor subtype 2 (SSTR2), enabling receptor‑mediated tumor targeting for PET imaging
Routes of Administration
Goals & Uses
- Neuroendocrine tumor imagingDiagnosisModerate
Contraindications
- PregnancyPopulationHighPotential fetal risk or insufficient safety data
- BreastfeedingPopulationModeratePotential transfer into breast milk or insufficient safety data
Adverse Effects
- Allergic reaction to peptide or chelatorImmuneRare
- Radiation‑related dose exposureSystemicCommon
Drug Interactions
- Other radiopharmaceuticalsModerate
Population Constraints
- Pediatric patientsAgeRelative
Regulatory Status
- European UnionInvestigationalUnder clinical evaluation; not yet marketed
- United StatesInvestigationalInvestigational New Drug (IND) for PET imaging of neuroendocrine tumors
Evidence & Sources
No sources recorded yet.
Frequently Asked Questions
What is Copper oxodotreotide Cu-64?
Cu‑64‑labeled oxodotreotide is a radiopharmaceutical used experimentally for PET imaging of SSTR2‑expressing neuroendocrine tumors. The peptide chelates Cu‑64 via a DOTA moiety, providing high‑resolution PET signal.
What is Copper oxodotreotide Cu-64 used for?
Copper oxodotreotide Cu-64 is educationally associated with: Neuroendocrine tumor imaging. Educational only — not medical advice.
How is Copper oxodotreotide Cu-64 administered?
Recorded routes of administration: Intravenous.
What are the potential side effects of Copper oxodotreotide Cu-64?
Reported adverse effects include: Allergic reaction to peptide or chelator, Radiation‑related dose exposure. This list is not exhaustive — consult a qualified clinician.
Who should avoid Copper oxodotreotide Cu-64?
Recorded contraindications: Pregnancy, Breastfeeding. Consult a qualified clinician before use.